“Kate and I have worked together for >5 years on two products, Epidiolex and nabiximols. She has built an exceptional medical affairs group in preparation and successful launch of the first, and is an invaluable product development team (PDT) core member preparing for US registration and launch of the second. A neuroscientist to rival the R&D functions, a communicator and educator to rival the comms professionals, a custodian of good governance, and champion of a robust and agile operating model, Kate wears many hats with justifiable confidence and is a prized partner to me as PDT lead and key collaborator for PDT members and the wider organization.”
About
Contributions
-
How can you build team confidence and productivity during times of uncertainty?
Normalize and celebrate failure. It should be easy enough to celebrate success, but success is sustainable and repeatable when the path has been forged by failures. In times of uncertainty, individuals become afraid to take the risks that innovation brings with it. If you can encourage your team to try ideas and then come back to the team with their learnings, failure becomes part of the effort and learning process. A celebration of learning through failure AND success fosters creativity and strengthens confidence.
Activity
-
I had the proudest year of my career. (But my boss ruined it in 5 mins) Cue: the most embarrassing night of my life. It was my 1st year in a new…
I had the proudest year of my career. (But my boss ruined it in 5 mins) Cue: the most embarrassing night of my life. It was my 1st year in a new…
Liked by Kathryn Nichol
-
As we go through photos from the conference, we can't help but feel immense gratitude for such an amazing event, amazing people, and amazing times…
As we go through photos from the conference, we can't help but feel immense gratitude for such an amazing event, amazing people, and amazing times…
Liked by Kathryn Nichol
-
So proud to be a part of this organization! #BetterTogether #EpilepsyResearch
So proud to be a part of this organization! #BetterTogether #EpilepsyResearch
Liked by Kathryn Nichol
Experience & Education
Licenses & Certifications
Volunteer Experience
-
Coach
USA Rugby
- 14 years 11 months
Education
Coach of Premier League, All-Star, Club, and Collegiate level rugby teams, men's and women's.
-
Board Member
Sanderling Waldorf School
- Present 2 years 3 months
Education
Advance initiatives that support education within Waldorf model.
Publications
-
Source of Cannabis Information and Medical Guidelines for Neurologic Use: NARCOMS survey of People Living with Multiple Sclerosis
Neurology: Clinical Practice
Background and objectives: As cannabis products become increasingly accessible across the United States, understanding how patients obtain medical information on cannabis and view the role of their health care provider in providing information is important.
Methods: Participants with multiple sclerosis (MS) from the North American Research Committee on Multiple Sclerosis registry completed a supplemental survey on Δ9-tetrahydrocannabinol-containing cannabis use between March and April…Background and objectives: As cannabis products become increasingly accessible across the United States, understanding how patients obtain medical information on cannabis and view the role of their health care provider in providing information is important.
Methods: Participants with multiple sclerosis (MS) from the North American Research Committee on Multiple Sclerosis registry completed a supplemental survey on Δ9-tetrahydrocannabinol-containing cannabis use between March and April 2020. Participants reported dialogue with health care providers regarding cannabis use, information sources used to make product decisions, and expenditure on cannabis. Findings are reported using descriptive statistics.
Results: Overall, 3,249 participants responded (47% response rate), of whom 31% ever used cannabis and 20% currently used cannabis for MS. To determine presumed cannabis contents, respondents who had ever used cannabis (ever users) most often used dispensary-provided information (39%), word of mouth/dealer/friend (29%), and unregulated product labels (24%). For general information on cannabis for MS, ever users most often used dispensary staff (38%) and friends (32%). The primary source of medical guidance among ever users was most often "nobody or myself" (48%), followed by a dispensary professional (21%); only 12% relied on their MS physician, although 70% had discussed cannabis with their MS physician. Most current users (62%) typically sourced their cannabis from a dispensary. The most common factor in selecting a cannabis product was perceived quality and safety (70%).
Discussion: Participants most often received information on cannabis for MS from dispensaries, unregulated product labels, and friends; only a small proportion used health care providers. Evidence-based patient and physician education is needed.Other authorsSee publication -
A Survey of Cannabis Use in a Large US-Based Cohort of People with Multiple Sclerosis
Int J MS Care
Background: As cannabis products become increasingly accessible across the United States, it is important to understand the contemporary use of cannabis for managing multiple sclerosis (MS) symptoms. Methods: We invited participants with MS from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry (aged 18 years or older) to complete a supplemental survey on cannabis use between March and April 2020. Participants reported cannabis use, treated symptoms, patterns…
Background: As cannabis products become increasingly accessible across the United States, it is important to understand the contemporary use of cannabis for managing multiple sclerosis (MS) symptoms. Methods: We invited participants with MS from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry (aged 18 years or older) to complete a supplemental survey on cannabis use between March and April 2020. Participants reported cannabis use, treated symptoms, patterns, preferences, methods of use, and the factors limiting use. Findings are reported using descriptive statistics. Results: Of the 6934 participants invited, 3249 responded. Of the respondents, 31% reported having ever used cannabis to treat MS symptoms, with 20% currently using cannabis. The remaining 69% had never used cannabis for MS symptoms, for reasons including not enough data about efficacy (40%) and safety (27%), and concerns about legality (25%) and cost (18%). The most common symptoms current users were attempting to treat were spasticity (80%), pain (69%), and sleep problems (61%). Ever users (vs never users) were more likely to be younger, be non-White, have lower education, reside in the Northeast and West, be unemployed, be younger at symptom onset, be currently smoking, and have higher levels of disability and MS-related symptoms (all P < .001). Conclusions: Despite concerns about insufficient safety and efficacy data, legality, and cost, almost one-third of NARCOMS Registry respondents report having tried nonprescription cannabis products in an attempt to alleviate their symptoms. Given the lack of efficacy and safety data on such products, future research in this area is warranted. Int J MS Care. 2021;23:245-252.
Other authorsSee publication -
Long Term Safety and Efficacy of Cannabidiol in Children and Adults with Treatment-Resistant LGS or Dravet: Expanded Access Program Results
Epilepsy Research
Since 2014, patients with severe treatment-resistant epilepsies (TREs) have been receiving add-on cannabidiol (CBD) in an ongoing, expanded access program (EAP), which closely reflects clinical practice. We conducted an interim analysis of long-term efficacy and tolerability in patients with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) who received CBD treatment through December 2016. Results from this interim analysis support add-on CBD as an effective long-term treatment option in…
Since 2014, patients with severe treatment-resistant epilepsies (TREs) have been receiving add-on cannabidiol (CBD) in an ongoing, expanded access program (EAP), which closely reflects clinical practice. We conducted an interim analysis of long-term efficacy and tolerability in patients with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) who received CBD treatment through December 2016. Results from this interim analysis support add-on CBD as an effective long-term treatment option in LGS or DS.
-
Clobazam and Its Active Metabolite N-desmethylclobazam Display Significantly Greater Affinities for α2- versus α1-GABAA-Receptor Complexes.
PLoS One
Our results demonstrate that CLB and N-CLB have significantly greater binding affinities for α2- vs. α1-receptor complexes, a difference not observed for CLN, for which no distinction between α2 and α1 receptors was observed. These results provide potential clues to a new understanding of the pharmacologic modes of action of CLB and N-CLB
Other authorsSee publication -
Cardiovascular fitness is associated with altered cortical glucose metabolism during working memory in ɛ4 carriers.
Alzheimers & Dementia
BACKGROUND: The possibility that ɛ4 may modulate the effects of fitness in the brain remains controversial. The present exploratory FDG-PET study aimed to better understand the relationship among ɛ4, fitness, and cerebral metabolism in 18 healthy aged women (nine carriers, nine noncarriers) during working memory.
METHODS: Participants were evaluated using maximal level of oxygen consumption, California Verbal Learning Test, and FDG-PET, which were collected at rest and during completion…BACKGROUND: The possibility that ɛ4 may modulate the effects of fitness in the brain remains controversial. The present exploratory FDG-PET study aimed to better understand the relationship among ɛ4, fitness, and cerebral metabolism in 18 healthy aged women (nine carriers, nine noncarriers) during working memory.
METHODS: Participants were evaluated using maximal level of oxygen consumption, California Verbal Learning Test, and FDG-PET, which were collected at rest and during completion of the Sternberg working memory task.
RESULTS: Resting FDG-PET did not differ between carriers and noncarriers. Significant effects of fitness on FDG-PET during working memory were noted in the ɛ4 carriers only. High fit ɛ4 carriers had greater glucose uptake in the temporal lobe than the low fit ɛ4 carriers, but low fit ɛ4 carriers had greater glucose uptake in the frontal and parietal lobes.
CONCLUSIONS: We demonstrate that fitness differentially affects cerebral metabolism in ɛ4 carriers only, consistent with previous findings that the effects of fitness may be more pronounced in populations genetically at risk for cognitive decline.
Other authorsSee publication -
Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice.
Alzheimers & Dementia
Physical activity interacts with genotype known to confer risk of Alzheimer's disease, apolipoprotein E4. Exercise improves cognition and alters synaptic proteins in mouse model of genetic risk.
Other authorsSee publication -
Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid.
Journal of Neuroinflammation
Inflammation cascades change during the course of Alzheimer's disease. Physical exercise alters these changes and decreases some forms of amyloid associated with the progression of dementia.
Other authorsSee publication -
Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2.
J Neuroscience
Alzheimer's disease (AD) is characterized by the accumulation of plaques containing beta-amyloid (Abeta) and neurofibrillary tangles (NFTs) consisting of modified tau. Although Abeta deposition is thought to precede the formation of NFTs in AD, the molecular steps connecting these two pathologies is not known. Previous studies have suggested that caspase activation plays an important role in promoting the pathology associated with AD. To further understand the contribution of caspases in…
Alzheimer's disease (AD) is characterized by the accumulation of plaques containing beta-amyloid (Abeta) and neurofibrillary tangles (NFTs) consisting of modified tau. Although Abeta deposition is thought to precede the formation of NFTs in AD, the molecular steps connecting these two pathologies is not known. Previous studies have suggested that caspase activation plays an important role in promoting the pathology associated with AD. To further understand the contribution of caspases in disease progression, a triple transgenic Alzheimer's mouse model overexpressing the anti-apoptotic protein Bcl-2 was generated. Here we show that overexpression of Bcl-2 limited caspase-9 activation and reduced the caspase cleavage of tau. Moreover, overexpression of Bcl-2 attenuated the processing of APP (amyloid precursor protein) and tau and reduced the number of NFTs and extracellular deposits of Abeta associated with these animals. In addition, overexpression of Bcl-2 in 3xTg-AD mice improved place recognition memory. These findings suggest that the activation of apoptotic pathways may be an early event in AD and contributes to the pathological processes that promote the disease mechanisms underlying AD.
Other authorsSee publication -
Three weeks of running wheel exposure improves cognitive performance in the aged Tg2576 mouse.
Brain Behaviour Research
Physical exercise improves cognitive performance in aged mouse models of Alzheimer's.
Other authorsSee publication -
Regulation of nitric oxide-dependent vasodilation in coronary arteries of estrogen receptor-alpha-deficient mice.
Am J Physiol Heart Circ Physiol
Estrogen has been shown to increase endothelium-dependent vasodilation and expression of endothelial nitric oxide (NO) synthase (eNOS); however, the role of estrogen receptors in mediating estrogen effects on endothelial function remains to be elucidated. The purpose of this study was to test the hypothesis that estrogen modulates NO-dependent vasodilation of coronary arteries through its action on estrogen receptor-alpha (ER-alpha) to increase protein levels of eNOS and Cu/Zn superoxide…
Estrogen has been shown to increase endothelium-dependent vasodilation and expression of endothelial nitric oxide (NO) synthase (eNOS); however, the role of estrogen receptors in mediating estrogen effects on endothelial function remains to be elucidated. The purpose of this study was to test the hypothesis that estrogen modulates NO-dependent vasodilation of coronary arteries through its action on estrogen receptor-alpha (ER-alpha) to increase protein levels of eNOS and Cu/Zn superoxide dismutase (SOD-1). Vasodilation to acetylcholine (ACh) and sodium nitroprusside was assessed in isolated coronary arteries from intact and ovariectomized female wild-type (WT) and ER-alpha knockout (ERalphaKO) mice. Protein levels for eNOS and SOD-1 were also evaluated. Vasodilation to ACh was not significantly altered in ERalphaKO mice compared with WT mice. Ovariectomy reduced responsiveness to ACh in ERalphaKO mice but not WT mice. Responses to sodium nitroprusside were not altered by disruption of ER-alpha or by ovariectomy. Supplementation with estrogen restored ACh-induced vasodilation in ovariectomized ERalphaKO mice. eNOS protein was reduced in ERalphaKO mice compared with WT mice. Ovariectomy caused a further reduction in eNOS protein in ERalphaKO mice, but this reduction was reversed by estrogen treatment. SOD-1 protein levels were increased by disruption of ER-alpha. Ovariectomy reduced SOD-1 protein in ERalphaKO mice, but this reduction was partially reversed by estrogen replacement. These results suggest that estrogen modulation of eNOS protein content is mediated in part through ER-alpha. NO-dependent responses are preserved in ERalphaKO mice, possibly through increased SOD-1 expression and enhanced bioavailability of NO.
Other authorsSee publication -
Bcl-2 family protein behavior in frontotemporal dementia implies vascular involvement.
Neurology
Pro-apoptotic members of the Bcl-2 family are identified in white matter and astrocytes in post-mortem cortex from fronto-temporal dementia patients.
Other authorsSee publication
Organizations
-
Healthcare Business Women's Association
-
- Present
Recommendations received
7 people have recommended Kathryn
Join now to viewMore activity by Kathryn
-
The biggest mistake about leadership: Thinking ONLY those in top positions can be leaders. Here are 11 signs of true leaders: 1. They lead by…
The biggest mistake about leadership: Thinking ONLY those in top positions can be leaders. Here are 11 signs of true leaders: 1. They lead by…
Liked by Kathryn Nichol
-
Dr. Tracy Dixon-Salazar didn’t set out to become a neuroscientist or a geneticist; she just wanted to help her daughter. Her journey began about…
Dr. Tracy Dixon-Salazar didn’t set out to become a neuroscientist or a geneticist; she just wanted to help her daughter. Her journey began about…
Liked by Kathryn Nichol
-
Another great multi-center collaboration finding better answers for treatment of childhood #epilepsy from Pediatric Epilepsy Research Consortium! 💪
Another great multi-center collaboration finding better answers for treatment of childhood #epilepsy from Pediatric Epilepsy Research Consortium! 💪
Liked by Kathryn Nichol
-
The Brain Inflammation Collaborative Board of Directors is excited to welcome Julie Milder, PhD to our board! Julie Milder, PhD, currently serves as…
The Brain Inflammation Collaborative Board of Directors is excited to welcome Julie Milder, PhD to our board! Julie Milder, PhD, currently serves as…
Liked by Kathryn Nichol
-
Facing challenges accessing pediatric neurology? The Eysz HV Recorder can help you evaluate children with staring spells, ADHD, or mood symptoms to…
Facing challenges accessing pediatric neurology? The Eysz HV Recorder can help you evaluate children with staring spells, ADHD, or mood symptoms to…
Liked by Kathryn Nichol
-
Check out the first in a series of webinars titled – ‘Secrets of the EU Marketing Authorization Application: A Comprehensive Guide to Timelines and…
Check out the first in a series of webinars titled – ‘Secrets of the EU Marketing Authorization Application: A Comprehensive Guide to Timelines and…
Liked by Kathryn Nichol
-
I’m very excited for Longboard Pharmaceuticals and for the rare epilepsy space. At the Lennox-Gastaut Syndrome (LGS) Foundation meeting in Phoenix…
I’m very excited for Longboard Pharmaceuticals and for the rare epilepsy space. At the Lennox-Gastaut Syndrome (LGS) Foundation meeting in Phoenix…
Shared by Kathryn Nichol
-
I spent 2 years fixing a bad first impression. In my next job, I got it right. Here’s how you can too: ⭐ Whether you like it or not, first…
I spent 2 years fixing a bad first impression. In my next job, I got it right. Here’s how you can too: ⭐ Whether you like it or not, first…
Liked by Kathryn Nichol
-
I could not agree more. Having my kids at a media free school has helped me put my phone down when outside working hours. I cannot always manage it…
I could not agree more. Having my kids at a media free school has helped me put my phone down when outside working hours. I cannot always manage it…
Shared by Kathryn Nichol
Other similar profiles
-
Stephanie Bolton
Connect -
Jennifer L Marlo-Triemstra, MS, PhD, EMBA
Associate Medical Director - Cannabinoid Education
Connect -
Shaina D. Barnes, Pharm.D., MBA
Connect -
Steven Valliere
Director Neuromodulation Field Medical
Connect -
John Webb
Connect -
Jay Lutterman
Director of Commercial Excellence @ LivaNova | President's Club Winner, Coaching Skills
Connect -
Justine Cohen
Medical Science Liaison at LivaNova
Connect -
Sally Schaeffer
Connect -
Rich Wintersteller
Connect -
Matt Marquart
Connect
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore MoreOthers named Kathryn Nichol in United States
-
Kathryn Nichol
Gym Owner
-
Kathryn Nichol
Office of School Turnaround at New Hampshire Department of Education
-
Kathryn Nichol
Flight attendant at Endeavor Airlines
-
Kathryn Nichol
--
12 others named Kathryn Nichol in United States are on LinkedIn
See others named Kathryn Nichol